Tel.:
+34 91 736 2385
LOCAL TIME
Contact:
Katarina Gluic
Hours:
Mon-Thu 8:30-17:00 Fri 8:30-15:00
00:21
For help with a poster, please specify the poster number, the first author and the congress and we will reply shortly.
Poster no.
Contact name
E-mail
Telephone
Congress
Comments
54th ERA-EDTA Congress
3rd-6th June 2017 Madrid
About us
FAQs
Help Line
Personal Area
Homepage
Discussion forum -
54th ERA-EDTA Congress
Topic -
Registry posters
If you are already registered in PosterSessionOnline, enter your e-mail and click on LOGIN. Otherwise click on REGISTER
Thread / Poster
Author
Replies
Last reply
Survival of elderly patients with renal disease. Data from the Spanish Renal Disease Registry (2004-2015)
BEATRIZ MAHILLO DURÁN
1
5/25/2017 4:25:00 PM
Probability of receiving transplant in the Basque Country. Patients on the waiting list from 2011 to 2015
Escribano Jaione
1
5/25/2017 1:50:00 PM
Baseline characteristics patients undergoing renal replacement therapy in Andalusia: Year 2016
Laura Fuentes Sánchez
1
5/24/2017 6:51:00 PM
Trends in the incidence and prevalence of patients on RRT over the period 2002-2015 in the Republic of Macedonia
Stojceva Olivera
1
5/24/2017 12:24:00 AM
Evolution of the incidence and prevalence of patients in renal replacement therapy in Andalusia
Santamaria Olmo Rafael
1
5/23/2017 8:00:00 AM
Renal Registry of Turkey: Change of Renal Replacement Modalities in the Last 10 years
Nurhan Seyahi
1
5/23/2017 1:10:00 AM
Report on dialysis and kidney transplantation in Serbia 2011-2014. Compare to others
Simic Ogrizovic Sanja
1
5/21/2017 4:54:00 PM
Most viewed poster for this congress
Poster:
9
Visits:
267
Title:
Report on dialysis and kidney transplantation in Serbia 2011-2014. Compare to others
Authors:
Simic Ogrizovic Sanja ,
Centre:
Serbian society of nephrology
Poster most viewed in this topic
Poster:
9
Visits:
267
Title:
Report on dialysis and kidney transplantation in Serbia 2011-2014. Compare to others
Authors:
Simic Ogrizovic Sanja ,
Centre:
Serbian society of nephrology
About us
Terms and Conditions
Special Access
Commercial Web Access
Follow us on: